NCT06230250

Brief Summary

The use of pedicled dorsal flaps sparing the latissimus dorsi muscle (TDAP and MSLD flap) is a well-described reconstruction method in breast reconstruction after breast cancer. However, little data exists regarding patient satisfaction after this surgery. The main objective of this study was to evaluate patient satisfaction after unilateral total secondary breast reconstruction using a TDAP or MSLD flap.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

February 28, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

January 8, 2024

Last Update Submit

February 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction

    patient satisfaction by using BREAST questionnaire (0 to 100, and 100 is the best score)

    5 years

Secondary Outcomes (1)

  • Patient characteristics

    5 years

Eligibility Criteria

Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women who underwent unilateral secondary total breast reconstruction using a TDAP or MSLD flap.

You may qualify if:

  • Breast reconstruction using a TDAP or MSLD flap between January 1, 2018 and December 31, 2022
  • Major
  • Non opposition
  • Women with social security number

You may not qualify if:

  • Bilateral reconstruction
  • Partial reconstruction
  • Immediate reconstruction
  • Prophylactic reconstruction
  • Women who did'nt have a breast cancer
  • Women who don't finish their reconstruction
  • Women who don't want participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2024

First Posted

January 30, 2024

Study Start

October 1, 2023

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

February 28, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning three years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations